Topical formulations for administration of omega-3 fatty acids
AssigneeNostrum Laboratories, Inc.
InventorsNirmal Mulye, David Assoulin
Life of this patent
Estimating the term…
Abstract
A pharmaceutical formulation is provided, for application directly to human skin comprising about 5% to 50% by weight of omega-3 fatty acids derived from fish oil or a vegetable source. The formulation may be an ointment or water-based emulsion. The formulation may be used to treat skin diseases, cardiovascular conditions, and is also useful as a general skin care or beauty product that reverses the effect of aging on the skin.
Claims23
A pharmaceutical formulation for topical application directly to human skin consisting essentially of about 5% to about 50% by weight of omega-3 fatty acids, for the treatment of a disease responsive to omega-3 fatty acid therapy.
(canceled)
7-8. (canceled)
A method of administering omega-3 fatty acids to a patient, comprising applying directly to the skin of said patient a topical formulation consisting essentially of to about 5% to about 50% by weight of omega-3 fatty acids, for the treatment of a disease responsive to omega-3 fatty acid therapy.
A method of treating a skin disease in a human patient comprising applying directly to the skin of said patient a pharmaceutical formulation consisting essentially of about 10% to 50% by weight of omega-3 fatty acids derived from a marine species.
A method of reversing the effect of aging of the skin in a human patient, comprising applying directly to the skin of said patient a pharmaceutical formulation consisting essentially of about 10% to 50% by weight of omega-3 fatty acids.
A method of treating a medical condition in a human patient selected from one or more of elevated triglycerides, elevated LDL cholesterol, elevated VLDL cholesterol, and depressed HDL cholesterol, comprising applying directly to the skin a pharmaceutical formulation consisting essentially of about 5% to 50% by weight of omega-3 fatty acids.
A method of treating high triglycerides in a human patient, comprising applying directly to the skin of said patient a pharmaceutical formulation consisting essentially about 10% to 50% by weight of omega-3 fatty acids.
(canceled)
A pharmaceutical formulation for topical application directly to the skin of a mammal consisting essentially of about 5% to about 50% by weight of omega-3 fatty acids, for the treatment of a disease responsive to omega-3 fatty acid therapy.
Dependencies are inferred from the claim text.